These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33723390)

  • 41. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
    Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
    Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical Cancer by Integrated Bioinformatic Methods.
    Li X; Tian R; Gao H; Yan F; Ying L; Yang Y; Yang P; Gao Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818767455. PubMed ID: 29642758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ.
    Beskow AH; Josefsson AM; Gyllensten UB
    Int J Cancer; 2001 Sep; 93(6):817-22. PubMed ID: 11519043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
    Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
    Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women.
    Wu Y; Chen Y; Li L; Cao Y; Liu Z; Liu B; Du Z; Zhang Y; Chen S; Lin Z; Xu A
    Int J Cancer; 2006 Jun; 118(12):3006-11. PubMed ID: 16425277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.
    Yeasmin S; Nakayama K; Ishibashi M; Katagiri A; Iida K; Purwana IN; Nakayama N; Miyazaki K
    Clin Cancer Res; 2008 Mar; 14(6):1686-91. PubMed ID: 18347169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.
    Espinosa AM; Alfaro A; Roman-Basaure E; Guardado-Estrada M; Palma Í; Serralde C; Medina I; Juárez E; Bermúdez M; Márquez E; Borges-Ibáñez M; Muñoz-Cortez S; Alcántara-Vázquez A; Alonso P; Curiel-Valdez J; Kofman S; Villegas N; Berumen J
    PLoS One; 2013; 8(2):e55975. PubMed ID: 23405241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic utility of serum YKL-40 in patients with cervical cancer.
    Roslind A; Palle C; Johansen JS; Christensen IJ; Nielsen HJ; Mosgaard BJ
    Scand J Clin Lab Invest; 2020 Dec; 80(8):687-693. PubMed ID: 33186077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas.
    Tartour E; Gey A; Sastre-Garau X; Lombard Surin I; Mosseri V; Fridman WH
    J Natl Cancer Inst; 1998 Feb; 90(4):287-94. PubMed ID: 9486814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.
    Chen D; Enroth S; Liu H; Sun Y; Wang H; Yu M; Deng L; Xu S; Gyllensten U
    Oncotarget; 2016 Jul; 7(27):42216-42224. PubMed ID: 27285765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
    Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
    DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
    Wang K; Li Y; Wang J; Chen R; Li J
    Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The correlation analysis of miRNAs and target genes in metastasis of cervical squamous cell carcinoma.
    Zhou J; Liu X; Wang C; Li C
    Epigenomics; 2018 Mar; 10(3):259-275. PubMed ID: 29343084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developing a prognostic micro-RNA signature for human cervical carcinoma.
    How C; Pintilie M; Bruce JP; Hui AB; Clarke BA; Wong P; Yin S; Yan R; Waggott D; Boutros PC; Fyles A; Hedley DW; Hill RP; Milosevic M; Liu FF
    PLoS One; 2015; 10(4):e0123946. PubMed ID: 25880806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population.
    Chan PK; Cheung JL; Cheung TH; Lin CK; Siu SS; Yu MM; Tang JW; Lo KW; Yim SF; Wong YF; To KF; Ng HK; Chung TK
    Gynecol Oncol; 2007 Jun; 105(3):736-41. PubMed ID: 17379283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of novel DNA methylation markers in cervical cancer.
    Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
    Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma.
    Huang L; Zheng M; Zhou QM; Zhang MY; Yu YH; Yun JP; Wang HY
    Med Oncol; 2012 Dec; 29(4):2911-8. PubMed ID: 22274917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.